Levothyroxine Monotherapy: What Works Better for the Individual With Hypothyroidism?

Area of Science:

• Endocrinology
• Thyroidology
• Pharmacology

Background:

• Accurate diagnosis of hypothyroidism is crucial for evaluating treatment efficacy.
• A significant proportion of patients receiving thyroid hormone replacement are euthyroid at initiation.
• Non-hypothyroid symptoms are often incorrectly attributed to thyroid hormone deficiency.

Purpose of the Study:

• To evaluate objective data regarding the addition of liothyronine (LT3) to levothyroxine (LT4) therapy.
• To assess the correlation between symptoms and confirmed hypothyroidism responsive to thyroid hormone replacement.
• To review the utility of thyroid-stimulating hormone (TSH) and triiodothyronine (T3) levels in guiding treatment.

Main Methods:

• Narrative review of existing literature.
• Analysis of the reliability of TSH in predicting euthyroid status.
• Examination of T3 levels' correlation with symptoms and treatment outcomes.

Main Results:

• The reliability of TSH in predicting a euthyroid state was reviewed.
• The correlation between T3 levels and hypothyroid symptoms was examined.
• Patient satisfaction and preferences for T3-containing treatments were summarized.

Conclusions:

• Relying on symptoms for thyroid hormone treatment decisions can lead to misdiagnosis.
• Adjusting treatment based on TSH targets or low T3 levels does not consistently improve outcomes.
• Levothyroxine (LT4) monotherapy remains a primary treatment, with further research needed for symptomatic patients.